Study: Good outcomes associated with use of bone graft substitute

Use of an injectable antibiotic eluting bone substitute as an off-the-shelf defect filler in patients with osteomyelitis was safe and associated with good clinical outcomes, according to results of a recently presented study. Between March 2013 and November 2013, Martin McNally, an honorary senior clinical lecturer at the University of Oxford and lead surgeon of the Bone Infection Unit at the Nuffield Orthopaedic Centre in Oxford, England, and colleagues treated 41 patients with debridement, implantation of an injectable antibiotic eluting bone substitute (Cerament G, Bonesupport, Lund, Sweden) and soft tissue closure and systemic antibiotics.

Use of an injectable antibiotic eluting bone substitute as an off-the-shelf defect filler in patients with osteomyelitis was safe and associated with good clinical outcomes, according to results of a recently presented study. Between March 2013 and November 2013, Martin McNally, an honorary senior clinical lecturer at the University of Oxford and lead surgeon of the Bone Infection Unit at the Nuffield Orthopaedic Centre in Oxford, England, and colleagues treated 41 patients with debridement, implantation of an injectable antibiotic eluting bone substitute (Cerament G, Bonesupport, Lund, Sweden) and soft tissue closure and systemic antibiotics.

Read More:
Study: Good outcomes associated with use of bone graft substitute